我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
17
5 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1989
进行中（未招募）
1
5.9%
已完成
7
41.2%
Enrolling By Invitation
尚未招募
3
17.6%
招募中
5
29.4%
暂无批准数据
- Intalight has received CE Mark approval for its DREAM OCT platform, allowing commercialization in the European Union with advanced imaging capabilities that deliver 130-degree OCTA images. - The DREAM OCT features swept-source 12mm super-depth scanning that images the choroid, retina, and vitreous space, with anterior scanning reaching 16.2mm to capture the complete anterior segment in a single scan. - Over 160 peer-reviewed papers have utilized findings from DREAM OCT devices, with the technology currently being used in retina academic institutions and private practices across the US, Europe, and Asia.
